Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding Cessation of Ms Maithreyi Jagannathan as Category leader- Health Care of the company w.e.f. December 31, 2025.

Management Changes View source PDF Explain this filing

PGHH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹12822.00

prior close

₹12788.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%+0.0% vs market

Personal Care peers, median of 12sector-0.7%+0.6% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 0.6 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-0.2+0.0-0.7+0.6

Next day

-1.0-0.8-0.2-0.7-0.2

-1.4-1.2-0.2-2.1+0.7

-1.2-1.8+0.6-1.3+0.1

-1.6-2.9+1.3-0.8-0.8

-0.6-5.2+4.6-3.2+2.6

-1.7-3.9+2.2-3.5+1.8

15d

+1.3-2.0+3.3-3.4+4.7

+1.4-2.3+3.6-2.8+4.2

-8.3-9.1+0.8+0.4-8.8

-12.3-9.9-2.4-0.6-11.7

UpDownMarket · Nifty Microcap 250Sector · Personal Care peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Procter & Gamble Hygiene and Health Care Limited has informed the exchange about the departure of Ms Maithreyi Jagannathan from her role as Category Leader for the Health Care vertical, with effect from December 31, 2025. The announcement does not mention any board-level or statutory KMP designation for her. No reasons for the cessation have been disclosed in this filing.

Likely market impact

This is an internal leadership change at the operational level and is unlikely to materially affect shareholder value or stock price. Investors should watch for any related disclosures about successor appointment or strategic shifts in the Health Care segment.